Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine

[1] Asakawa A(2003)Leptin treatment ameliorates anxiety in ob/ob obese mice J Diabetes Complicat 17 105-107

[2] Inui A(2002)Serum leptin and cholesterol levels in patients with bipolar disorder Neuropsychobiology 46 176-179

[3] Inui T(2001)Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635 Int J Neuropsychopharmacol 4 399-408

[4] Katsuura G(2005)Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline J Clin Psychiatry 66 94-99

[5] Fujino MA(2001)An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice Behav Pharmacol 12 151-162

[6] Kasuga M(2004)Glutamate and anxiety Eur Neuropsychopharmacol 14 175-183

[7] Atmaca M(2003)New drug development for post-traumatic stress disorder Curr Opin Investig Drugs 4 37-41

[8] Kuloglu M(2000)Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351-354

[9] Tezcan E(2003)Pharmacological treatment of social anxiety disorder: a meta-analysis Depress Anxiety 18 29-40

[10] Ustundag B(2003)Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 160 1432-1438

[1] Asakawa A(2003)Leptin treatment ameliorates anxiety in ob/ob obese mice J Diabetes Complicat 17 105-107

[2] Inui A(2002)Serum leptin and cholesterol levels in patients with bipolar disorder Neuropsychobiology 46 176-179

[3] Inui T(2001)Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635 Int J Neuropsychopharmacol 4 399-408

[4] Katsuura G(2005)Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline J Clin Psychiatry 66 94-99

[5] Fujino MA(2001)An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice Behav Pharmacol 12 151-162

[6] Kasuga M(2004)Glutamate and anxiety Eur Neuropsychopharmacol 14 175-183

[7] Atmaca M(2003)New drug development for post-traumatic stress disorder Curr Opin Investig Drugs 4 37-41

[8] Kuloglu M(2000)Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351-354

[9] Tezcan E(2003)Pharmacological treatment of social anxiety disorder: a meta-analysis Depress Anxiety 18 29-40

[10] Ustundag B(2003)Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 160 1432-1438